Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 200 Total
ANVS - Annovis Bio Inc - Stock Price Chart
TickerANVS [NYSE]
CompanyAnnovis Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap140.27MEPS (ttm)-6.22
P/E-EPS this Y50.87%
Forward P/E-EPS next Y2.92%
PEG-EPS past 5Y-126.41%
P/S-EPS next 5Y-
P/B-EPS Q/Q-515.14%
Dividend-Sales Q/Q-
Insider Own26.05%Inst Own11.44%
Insider Trans0.00%Inst Trans-3.09%
Short Float17.85%EarningsApr 04/a
Analyst Recom1.40Target Price35.40
Avg Volume229.78K52W Range5.42 - 22.49
Apr-24-24 09:55AM Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade (Zacks) +7.24%
Apr-08-24 09:55AM Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High? (Zacks)
Apr-02-24 12:53PM ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023 (InvestorPlace) -6.52%
07:30AM Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Apr-01-24 08:00AM Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in Humans (GlobeNewswire)
Mar-21-24 09:55AM Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet (Zacks) +6.58%
Mar-20-24 07:30AM Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer's Disease (GlobeNewswire) +24.44%
Mar-18-24 08:52AM Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock? (Zacks)
Mar-06-24 03:33PM Sell Signal: 3 Stocks to Unload Before the Bubble Bursts (InvestorPlace)
Feb-27-24 08:00AM Annovis Bio Announces Participation in Forum Discussion at AD/PD 2024 (GlobeNewswire) +10.37%
GCTS - GCT Semiconductor Holding Inc. - Stock Price Chart
TickerGCTS [NYSE]
CompanyGCT Semiconductor Holding Inc.
CountryUSA
IndustrySemiconductors
Market Cap41.63MEPS (ttm)-0.16
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.49EPS Q/Q-190.67%
Dividend-Sales Q/Q-
Insider Own4.68%Inst Own38.81%
Insider Trans0.00%Inst Trans-19.55%
Short Float5.35%Earnings-
Analyst Recom-Target Price-
Avg Volume894.29K52W Range3.80 - 56.00
Apr-05-24 08:00AM Aramco and GCT Semiconductor Holding, Inc. Sign MOU to Accelerate the Development of the 4G and 5G Ecosystem in Saudi Arabia (Business Wire) +42.41%
Apr-01-24 08:00AM GCT Semiconductor Appoints Nelson C. Chan to Board of Directors (Business Wire) -45.28%
Mar-26-24 06:30PM GCT Semiconductor Becomes a Publicly Traded Company After Completing Business Combination with Concord Acquisition Corp III, Will Commence Trading on NYSE Under Ticker Symbol "GCTS" (Business Wire) -34.46%
Mar-22-24 04:00PM GCT Semiconductor Announces Appointment of Edmond Cheng as Chief Financial Officer (Business Wire) -10.72%
Feb-15-24 04:00PM GCT Semiconductor and Concord Acquisition Corp III Announce Effectiveness of Registration Statement on Form S-4 (Business Wire)
Jan-25-24 08:00AM Concord Acquisition Corp III Receives Noncompliance Notification from the New York Stock Exchange Regarding Minimum Public Stockholders (PR Newswire)
Nov-03-23 08:00AM GCT Semiconductor to Become Publicly Listed via Merger with Concord Acquisition Corp III, Enhancing the 5G Silicon Ecosystem (Business Wire)
LAZR - Luminar Technologies Inc - Stock Price Chart
TickerLAZR [NASD, RUT]
CompanyLuminar Technologies Inc
CountryUSA
IndustryAuto Parts
Market Cap603.30MEPS (ttm)-1.47
P/E-EPS this Y20.43%
Forward P/E-EPS next Y31.26%
PEG-EPS past 5Y-416.28%
P/S8.65EPS next 5Y43.50%
P/B-EPS Q/Q8.97%
Dividend-Sales Q/Q98.76%
Insider Own34.46%Inst Own29.30%
Insider Trans0.00%Inst Trans1.71%
Short Float30.83%EarningsMay 07/a
Analyst Recom2.27Target Price5.09
Avg Volume7.78M52W Range1.21 - 8.32
Apr-23-24 02:03PM Luminar unveils new compact lidar sensor Halo, tie-up with Applied Intuition (Reuters) +12.31%
02:00PM Luminar Day: A New Era Luminar Achieves Global Start of Production for Volvo Cars (Business Wire)
02:00PM Applied Intuition and Luminar Partner to Accelerate ADAS and AD Development for Automakers (Business Wire)
Apr-22-24 06:15PM Luminar Technologies, Inc. (LAZR) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Apr-16-24 07:00AM 7 Consumer Discretionary Stocks Short Sellers are Betting Will Fall from Grace (InvestorPlace)
Apr-15-24 09:00AM Luminar to Report Q124 Financial Results on May 7, 2024 (Business Wire)
Apr-12-24 12:53PM Luminar Attracts Former Executives From Lyft, Apple and Meta, Microsoft (Business Wire) -9.72%
Apr-11-24 03:22PM Luminar Technologies Stock Slides After Downgrade. Why BofA Says to Sell. (Barrons.com) -18.18%
Apr-09-24 02:59PM Navigating the Robotics Landscape: ROBOs Q1 2024 Index Rebalance (ETF Trends)
Mar-31-24 06:34AM $1,000 Invested in These 7 Stocks Could Make You a Millionaire (InvestorPlace)
DWSN - Dawson Geophysical Company - Stock Price Chart
TickerDWSN [NASD]
CompanyDawson Geophysical Company
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap47.45MEPS (ttm)-0.46
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y15.68%
P/S0.49EPS next 5Y41.80%
P/B1.51EPS Q/Q41.47%
Dividend0.00%Sales Q/Q65.45%
Insider Own0.00%Inst Own87.73%
Insider Trans-Inst Trans0.12%
Short Float0.02%EarningsNov 09/b
Analyst Recom2.00Target Price4.00
Avg Volume22.07K52W Range1.08 - 2.26
Apr-01-24 02:53PM DWSN Stock Earnings: Dawson Geophysical Reported Results for Q4 2023 (InvestorPlace) +20.42%
06:10AM Dawson Geophysical: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM DAWSON GEOPHYSICAL REPORTS FOURTH QUARTER AND YEAR END 2023 RESULTS (PR Newswire)
Nov-09-23 07:04AM Dawson Geophysical Co (DWSN) Reports Third Quarter 2023 Results (GuruFocus.com)
06:42AM Dawson Geophysical: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM DAWSON GEOPHYSICAL REPORTS THIRD QUARTER 2023 RESULTS (PR Newswire)
Jul-31-23 06:09AM Dawson Geophysical: Q2 Earnings Snapshot (Associated Press Finance) -5.83%
06:00AM DAWSON GEOPHYSICAL REPORTS SECOND QUARTER 2023 RESULTS (PR Newswire)
May-15-23 04:44PM Dawson Geophysical: Q1 Earnings Snapshot (AP Finance)
04:30PM DAWSON GEOPHYSICAL REPORTS FIRST QUARTER 2023 RESULTS (PR Newswire)
ZURA - Zura Bio Ltd - Stock Price Chart
TickerZURA [NASD, RUT]
CompanyZura Bio Ltd
CountryUSA
IndustryBiotechnology
Market Cap144.28MEPS (ttm)-4.39
P/E-EPS this Y50.56%
Forward P/E-EPS next Y-13.87%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.43EPS Q/Q-641.35%
Dividend-Sales Q/Q-
Insider Own56.64%Inst Own47.93%
Insider Trans-2.54%Inst Trans2.60%
Short Float2.27%EarningsMar 28/b
Analyst Recom1.00Target Price19.33
Avg Volume292.38K52W Range2.00 - 14.00
Today 02:18AM Director Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA) (GuruFocus.com)
Apr-18-24 09:22AM Zura Bio Announces Oversubscribed $112.5 Million Private Placement (Business Wire) +17.89%
Apr-08-24 06:00AM Zura Bio Announces Robert Lisicki as CEO and Director (Business Wire)
Mar-28-24 11:54AM ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023 (InvestorPlace) +10.78%
06:00AM Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer (Business Wire)
Mar-04-24 06:00AM Zura Bio Announces Participation at March Conferences (Business Wire)
Feb-02-24 06:00AM Zura Bio Announces Participation at February Investor Conferences (Business Wire) +6.11%
Jan-08-24 06:00AM Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO (Business Wire)
Jan-03-24 06:00AM Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit (Business Wire)
Dec-04-23 06:00AM Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok (Business Wire)
MODV - ModivCare Inc - Stock Price Chart
TickerMODV [NASD, RUT]
CompanyModivCare Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap352.73MEPS (ttm)-14.43
P/E-EPS this Y-22.80%
Forward P/E4.33EPS next Y32.68%
PEG-EPS past 5Y-49.24%
P/S0.13EPS next 5Y6.99%
P/B2.26EPS Q/Q24.74%
Dividend-Sales Q/Q7.48%
Insider Own1.98%Inst Own106.61%
Insider Trans0.00%Inst Trans-4.83%
Short Float6.65%EarningsMay 02/a
Analyst Recom2.33Target Price46.60
Avg Volume290.53K52W Range19.64 - 73.24
Apr-11-24 09:00AM Modivcare to Report First Quarter 2024 Financial Results (Business Wire)
Mar-27-24 06:12PM GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600 (PR Newswire)
Mar-06-24 09:00AM Modivcares NEMT Mobility App for Members Sets Best-in-Class Rankings and User Adoption, Pioneers New Advancements (Business Wire)
Feb-24-24 09:11AM ModivCare Inc. (NASDAQ:MODV) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-22-24 04:05PM Modivcare Reports Fourth Quarter and Full Year 2023 Financial Results; Issues 2024 Guidance (Business Wire)
Feb-12-24 09:00AM Modivcare and Jobs & Hope West Virginia Partnership Transforms Lives Across the State (Business Wire) +5.73%
Feb-01-24 09:00AM Modivcare to Report Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Jan-17-24 09:00AM Modivcare Appoints New Chief Commercial Officer and Chief Strategy and Innovation Officer (Business Wire)
Dec-28-23 09:00AM Modivcare to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-06-23 09:00AM Modivcare to Present at Upcoming Investor Conferences (Business Wire)
JAN - JanOne Inc - Stock Price Chart
TickerJAN [NASD]
CompanyJanOne Inc
CountryUSA
IndustryBiotechnology
Market Cap41.06MEPS (ttm)-4.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q-9.46%
Dividend-Sales Q/Q-100.00%
Insider Own11.05%Inst Own3.61%
Insider Trans0.00%Inst Trans-7.88%
Short Float1.93%Earnings-
Analyst Recom-Target Price-
Avg Volume313.42K52W Range0.22 - 5.08
Mar-15-24 09:00AM JanOne Regains Compliance with Nasdaq's Listing Requirements (PR Newswire)
Nov-09-23 08:05AM Why Is JanOne (JAN) Stock Up 40% Today? (InvestorPlace) +64.75%
Sep-21-23 11:30AM JanOne to Present at the Dawson James 8th Annual Investment Conference (PR Newswire)
09:35AM Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Aug-31-23 01:30PM JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference (PR Newswire) -23.58%
Aug-29-23 01:30PM JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain (PR Newswire)
Aug-25-23 02:30PM JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting (PR Newswire)
Aug-22-23 05:30PM JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire) -6.31%
Aug-18-23 07:00PM JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire) +5.64%
12:42PM JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting (PR Newswire)
NTIP - Network-1 Technologies Inc - Stock Price Chart
TickerNTIP [AMEX]
CompanyNetwork-1 Technologies Inc
CountryUSA
IndustrySpecialty Business Services
Market Cap43.96MEPS (ttm)-0.06
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S16.91EPS next 5Y-
P/B0.87EPS Q/Q126.78%
Dividend5.35%Sales Q/Q-
Insider Own40.33%Inst Own22.11%
Insider Trans0.00%Inst Trans-1.33%
Short Float0.01%Earnings-
Analyst Recom-Target Price-
Avg Volume13.37K52W Range1.95 - 2.60
Mar-08-24 05:00PM Network-1 Reports 2023 Year-End Financial Results (ACCESSWIRE)
Mar-01-24 08:45AM Network-1 Receives New Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 51 Patents Worldwide (ACCESSWIRE)
Feb-23-24 12:30PM Network-1 Declares Semi-Annual Dividend (ACCESSWIRE)
Nov-02-23 05:00PM Network-1 Reports Third Quarter Results (ACCESSWIRE)
Sep-18-23 07:10AM Network-1 Technologies Inc (NTIP): A Comprehensive Analysis of Its Dividend Performance (GuruFocus.com)
Sep-08-23 04:15PM Network-1 Declares Semi-Annual Dividend (ACCESSWIRE)
Sep-06-23 08:30AM ILiAD Biotechnologies Reports First-ever Demonstration of Protection Against B. pertussis Colonization in Phase 2b Human Challenge Study of BPZE1 Vaccine (ACCESSWIRE)
Aug-28-23 08:30AM Network-1 Receives New eSIM Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 50 Patents Worldwide (ACCESSWIRE)
Aug-10-23 05:25PM Network-1 Reports Second Quarter Results (ACCESSWIRE)
Jun-14-23 04:30PM Network-1 Extends its Share Repurchase Program (ACCESSWIRE)
AVTE - Aerovate Therapeutics Inc - Stock Price Chart
TickerAVTE [NASD, RUT]
CompanyAerovate Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap590.63MEPS (ttm)-2.87
P/E-EPS this Y-6.41%
Forward P/E-EPS next Y-1.35%
PEG-EPS past 5Y-114.14%
P/S-EPS next 5Y-
P/B5.38EPS Q/Q-20.76%
Dividend-Sales Q/Q-
Insider Own37.26%Inst Own65.28%
Insider Trans-2.55%Inst Trans4.38%
Short Float7.16%EarningsMar 25/a
Analyst Recom1.00Target Price44.67
Avg Volume152.74K52W Range9.41 - 32.42
Apr-04-24 01:31AM Aerovate Therapeutics Inc CEO Timothy Noyes Sells 10,000 Shares (GuruFocus.com)
Mar-27-24 09:20AM Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference (GlobeNewswire) +11.11%
Mar-26-24 09:01PM Aerovate Therapeutics Inc (AVTE) Reports Increased R&D Expenses and Net Loss in 2023 (GuruFocus.com)
Mar-25-24 09:53PM AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q4 2023 (InvestorPlace)
04:10PM Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights (GlobeNewswire)
Mar-21-24 02:32AM Chief Medical Officer Hunter Gillies Sells 7,000 Shares of Aerovate Therapeutics Inc (AVTE) (GuruFocus.com)
02:32AM Insider Sell: Aerovate Therapeutics Inc's (AVTE) Chief Technical Officer Marinus Verwijs Sells ... (GuruFocus.com)
Mar-06-24 08:00AM Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair (GlobeNewswire)
Dec-16-23 11:01AM Insider Sell Alert: Chief Medical Officer Hunter Gillies Sells 12,000 Shares of Aerovate ... (GuruFocus.com)
Nov-20-23 04:45PM Aerovate Therapeutics Announces Simultaneous Completion of Enrollment in Phase 2b Portion and Enrollment of First Patient into Phase 3 in the IMPAHCT Trial Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension (GlobeNewswire)
BFRI - Biofrontera Inc - Stock Price Chart
TickerBFRI [NASD]
CompanyBiofrontera Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap8.45MEPS (ttm)-15.82
P/E-EPS this Y75.08%
Forward P/E-EPS next Y83.20%
PEG-EPS past 5Y7.90%
P/S0.25EPS next 5Y-
P/B0.53EPS Q/Q178.97%
Dividend-Sales Q/Q4.46%
Insider Own27.98%Inst Own24.29%
Insider Trans0.00%Inst Trans-
Short Float1.20%EarningsMar 15/a
Analyst Recom1.00Target Price16.00
Avg Volume782.26K52W Range0.61 - 13.42
Mar-26-24 04:30PM Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals (ACCESSWIRE) -5.45%
Mar-19-24 09:22AM Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript (Insider Monkey) -6.35%
Mar-15-24 09:52PM BFRI Stock Earnings: Biofrontera Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -11.43%
08:25PM CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
06:10PM Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
Mar-08-24 09:00AM Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024 (ACCESSWIRE)
Feb-23-24 08:40AM Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules (ACCESSWIRE) -7.54%
Feb-20-24 08:10AM Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG (ACCESSWIRE) +53.44%
08:05AM Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules (ACCESSWIRE)
Feb-05-24 05:15PM Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use (ACCESSWIRE)
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.